8
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Expanding the clinical phenotype of IARS2-related mitochondrial disease

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          IARS2 encodes a mitochondrial isoleucyl-tRNA synthetase, a highly conserved nuclear-encoded enzyme required for the charging of tRNAs with their cognate amino acid for translation. Recently, pathogenic IARS2 variants have been identified in a number of patients presenting broad clinical phenotypes with autosomal recessive inheritance. These phenotypes range from Leigh and West syndrome to a new syndrome abbreviated CAGSSS that is characterised by cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia, as well as cataract with no additional anomalies.

          Methods

          Genomic DNA from Iranian probands from two families with consanguineous parental background and overlapping CAGSSS features were subjected to exome sequencing and bioinformatics analysis.

          Results

          Exome sequencing and data analysis revealed a novel homozygous missense variant (c.2625C > T, p.Pro909Ser, NM_018060.3) within a 14.3 Mb run of homozygosity in proband 1 and a novel homozygous missense variant (c.2282A > G, p.His761Arg) residing in an ~ 8 Mb region of homozygosity in a proband of the second family. Patient-derived fibroblasts from proband 1 showed normal respiratory chain enzyme activity, as well as unchanged oxidative phosphorylation protein subunits and IARS2 levels. Homology modelling of the known and novel amino acid residue substitutions in IARS2 provided insight into the possible consequence of these variants on function and structure of the protein.

          Conclusions

          This study further expands the phenotypic spectrum of IARS2 pathogenic variants to include two patients (patients 2 and 3) with cataract and skeletal dysplasia and no other features of CAGSSS to the possible presentation of the defects in IARS2. Additionally, this study suggests that adult patients with CAGSSS may manifest central adrenal insufficiency and type II esophageal achalasia and proposes that a variable sensorineural hearing loss onset, proportionate short stature, polyneuropathy, and mild dysmorphic features are possible, as seen in patient 1. Our findings support that even though biallelic IARS2 pathogenic variants can result in a distinctive, clinically recognisable phenotype in humans, it can also show a wide range of clinical presentation from severe pediatric neurological disorders of Leigh and West syndrome to both non-syndromic cataract and cataract accompanied by skeletal dysplasia.

          Electronic supplementary material

          The online version of this article (10.1186/s12881-018-0709-3) contains supplementary material, which is available to authorized users.

          Related collections

          Most cited references20

          • Record: found
          • Abstract: found
          • Article: not found

          Characterization of Greater Middle Eastern genetic variation for enhanced disease gene discovery

          The Greater Middle East (GME) has been a central hub of human migration and population admixture. The tradition of consanguinity, variably practiced in the Gulf region, North Africa, and Central Asia 1–3 , has resulted in an elevated burden of recessive disease 4 . Here we generated a whole exome GME variome from 1,111 unrelated subjects. We detected substantial diversity from sub-geographies, continental and subregional admixture, several ancient founder populations with little evidence of bottlenecks. Measured consanguinity was an order-of-magnitude above that of other sampled populations, and included an increased burden of runs of homozygosity (ROH), but no evidence for reduced burden of deleterious variation due to classically theorized ‘genetic purging’. Applying this database to unsolved GME recessive conditions reduced the number of potential disease-causing variants by 4–7-fold. These results reveal the variegated GME genetic architecture and support future human genetic discoveries in Mendelian and population genetics.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Ranking non-synonymous single nucleotide polymorphisms based on disease concepts

            As the number of non-synonymous single nucleotide polymorphisms (nsSNPs) identified through whole-exome/whole-genome sequencing programs increases, researchers and clinicians are becoming increasingly reliant upon computational prediction algorithms designed to prioritize potential functional variants for further study. A large proportion of existing prediction algorithms are ‘disease agnostic’ but are nevertheless quite capable of predicting when a mutation is likely to be deleterious. However, most clinical and research applications of these algorithms relate to specific diseases and would therefore benefit from an approach that discriminates between functional variants specifically related to that disease from those which are not. In a whole-exome/whole-genome sequencing context, such an approach could substantially reduce the number of false positive candidate mutations. Here, we test this postulate by incorporating a disease-specific weighting scheme into the Functional Analysis through Hidden Markov Models (FATHMM) algorithm. When compared to traditional prediction algorithms, we observed an overall reduction in the number of false positives identified using a disease-specific approach to functional prediction across 17 distinct disease concepts/categories. Our results illustrate the potential benefits of making disease-specific predictions when prioritizing candidate variants in relation to specific diseases. A web-based implementation of our algorithm is available at http://fathmm.biocompute.org.uk.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Emerging mechanisms of aminoacyl-tRNA synthetase mutations in recessive and dominant human disease.

              Aminoacyl-tRNA synthetases (ARSs) are responsible for charging amino acids to cognate tRNA molecules, which is the essential first step of protein translation. Interestingly, mutations in genes encoding ARS enzymes have been implicated in a broad spectrum of human inherited diseases. Bi-allelic mutations in ARSs typically cause severe, early-onset, recessive diseases that affect a wide range of tissues. The vast majority of these mutations show loss-of-function effects and impair protein translation. However, it is not clear how a subset cause tissue-specific phenotypes. In contrast, dominant ARS-mediated diseases specifically affect the peripheral nervous system-most commonly causing axonal peripheral neuropathy-and usually manifest later in life. These neuropathies are linked to heterozygosity for missense mutations in five ARS genes, which points to a shared mechanism of disease. However, it is not clear if a loss-of-function mechanism or a toxic gain-of-function mechanism is responsible for ARS-mediated neuropathy, or if a combination of these mechanisms operate on a mutation-specific basis. Here, we review our current understanding of recessive and dominant ARS-mediated disease. We also propose future directions for defining the molecular mechanisms of ARS mutations toward designing therapies for affected patient populations.
                Bookmark

                Author and article information

                Contributors
                +49-931-31-84244 , barbara.vona@uni-wuerzburg.de
                rmaroofian@gmail.com
                emanuele.bellacchio@opbg.net
                Maryam.najafi@radboudumc.nl
                kyle.thompson@ncl.ac
                a.alahmad@ncl.ac.uk
                langping.he@nuth.nhs.uk
                najmeh.ahangari@gmail.com
                rad6790@yahoo.com
                sima.shahrokhzade@yahoo.com
                paulina.bahena_carbajal@uni-wuerzburg.de
                falk.mittag@med.uni-tuebingen.de
                Frank.Traub@med.uni-tuebingen.de
                movaffaghj@mums.ac.ir
                AmiriN901@mums.ac.ir
                doosti.m@gmail.com
                boostanir@mums.ac.ir
                dreshirzad@yahoo.com
                thomas.haaf@uni-wuerzburg.de
                daria.diodato@opbg.net
                miriam.schmidts@radboudumc.nl
                robert.taylor@ncl.ac.uk
                +989153192327 , eghayoor@gmail.com
                Journal
                BMC Med Genet
                BMC Med. Genet
                BMC Medical Genetics
                BioMed Central (London )
                1471-2350
                12 November 2018
                12 November 2018
                2018
                : 19
                : 196
                Affiliations
                [1 ]ISNI 0000 0001 1958 8658, GRID grid.8379.5, Institute of Human Genetics, , Julius Maximilians University Würzburg, ; Würzburg, Germany
                [2 ]ISNI 0000 0001 2190 1447, GRID grid.10392.39, Department of Otorhinolaryngology, Head and Neck Surgery, Tübingen Hearing Research Centre (THRC), , Eberhard Karls University Tübingen, ; 72076 Tübingen, Germany
                [3 ]ISNI 0000000121901201, GRID grid.83440.3b, Genetics and Molecular Cell Sciences Research Centre, St George’s, , University of London, Cranmer Terrace, ; London, SW17 0RE UK
                [4 ]ISNI 0000 0001 0727 6809, GRID grid.414125.7, Genetics and Rare Diseases, Research Division, , ‘Bambino Gesù’ Children Hospital, ; Rome, Italy
                [5 ]GRID grid.461760.2, Genome Research Division, Human Genetics Department, , Radboud University Medical Center and Radboud Institute for Molecular Life Sciences, ; Geert Grooteplein Zuid 10, 6525KL, Nijmegen, The Netherlands
                [6 ]ISNI 0000 0001 0462 7212, GRID grid.1006.7, Wellcome Centre for Mitochondrial Research, Institute of Neuroscience, , Newcastle University, ; Newcastle upon Tyne, UK
                [7 ]ISNI 0000 0001 2198 6209, GRID grid.411583.a, Faculty of Medicine, , Mashhad University of Medical Sciences, ; Mashhad, Iran
                [8 ]Next Generation Genetic Clinic, Mashhad, Iran
                [9 ]ISNI 0000 0004 0610 7204, GRID grid.412328.e, Cellular and Molecular Research Center, , Sabzevar University of Medical Sciences, ; Sabzevar, Iran
                [10 ]ISNI 0000 0001 0196 8249, GRID grid.411544.1, Department of Orthopaedic Surgery, , University Hospital of Tübingen, ; Hoppe-Seyler-Strasse 3, 72076 Tübingen, Germany
                [11 ]Targeted Drug Delivery Research Center, Pharmaceutical Technology Institute, University of Medical Sciences, Mashhad, Iran
                [12 ]ISNI 0000 0001 2198 6209, GRID grid.411583.a, Department of Neurology, Faculty of Medicine, , Mashhad University of Medical Sciences, ; Mashhad, Iran
                [13 ]ISNI 0000 0004 0610 7204, GRID grid.412328.e, Sabzevar University of Medical Sciences, ; Sabzevar, Iran
                [14 ]ISNI 0000 0001 0727 6809, GRID grid.414125.7, Unit of Neuromuscular and Neurodegenerative Disorders, Laboratory of Molecular Medicine, ‘Bambino Gesu’ Children’s Research Hospital, ; Rome, Italy
                [15 ]Center for Pediatrics and Adolescent Medicine, University Hospital Freiburg, Faculty of Medicine, Mathildenstrasse 1, 79112 Freiburg, Germany
                Author information
                http://orcid.org/0000-0002-6719-3447
                Article
                709
                10.1186/s12881-018-0709-3
                6233262
                30419932
                817763c6-b8dd-488c-bbf0-59a08486ca7e
                © The Author(s). 2018

                Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

                History
                : 1 May 2018
                : 25 October 2018
                Funding
                Funded by: FundRef http://dx.doi.org/10.13039/100004440, Wellcome Trust;
                Award ID: 203105/Z/16/Z
                Award Recipient :
                Funded by: MRC Centre for Neuromuscular Diseases
                Award ID: G0601943
                Award Recipient :
                Funded by: UK NHS Highly Specialised "Rare Mitochondrial Disorders of Adults and Children" Service
                Funded by: The Lily Foundation
                Funded by: Kuwait Civil Service Commission
                Funded by: University of Würzburg Open Access Publishing
                Funded by: H2020 European Research Council (ERC starting grant TREATCilia)
                Award ID: 716344
                Award Recipient :
                Funded by: FundRef http://dx.doi.org/10.13039/501100001659, Deutsche Forschungsgemeinschaft;
                Award ID: DFG CRC1140 KIDGEM
                Award Recipient :
                Funded by: Radboudumc Nijmegen (Hypatia Tenure Track Fellowship)
                Categories
                Research Article
                Custom metadata
                © The Author(s) 2018

                Genetics
                adrenal insufficiency,cagsss,cataracts,growth hormone deficiency,iars2,sensory neuropathy,sensorineural hearing loss,skeletal dysplasia,type ii esophageal achalasia

                Comments

                Comment on this article